Insufficient scRNA-seq data for expression of MYL11 at single-cell level.
Insufficient scRNA-seq data for expression of MYL11 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 52% | 19.71 | 94 / 180 | 99% | 12.96 | 425 / 430 |
thymus | 76% | 59.56 | 494 / 653 | 71% | 2.24 | 431 / 605 |
uterus | 72% | 17.68 | 123 / 170 | 57% | 133.36 | 262 / 459 |
prostate | 77% | 177.64 | 188 / 245 | 26% | 3.99 | 129 / 502 |
breast | 74% | 81.34 | 338 / 459 | 28% | 1.01 | 312 / 1118 |
muscle | 100% | 109766.22 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.01 | 1 / 1 |
intestine | 60% | 22.12 | 581 / 966 | 36% | 0.79 | 191 / 527 |
skin | 77% | 43.70 | 1388 / 1809 | 16% | 0.44 | 76 / 472 |
pancreas | 58% | 17.34 | 190 / 328 | 35% | 0.67 | 62 / 178 |
lung | 67% | 25.60 | 387 / 578 | 26% | 0.90 | 295 / 1155 |
stomach | 48% | 14.20 | 172 / 359 | 39% | 0.77 | 111 / 286 |
bladder | 29% | 4.95 | 6 / 21 | 55% | 2.82 | 276 / 504 |
brain | 72% | 22.15 | 1891 / 2642 | 9% | 0.14 | 62 / 705 |
esophagus | 59% | 29.60 | 848 / 1445 | 21% | 0.40 | 38 / 183 |
blood vessel | 78% | 71.34 | 1045 / 1335 | 0% | 0 | 0 / 0 |
kidney | 62% | 13.08 | 55 / 89 | 16% | 0.27 | 140 / 901 |
adipose | 76% | 39.32 | 912 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 53% | 13.34 | 137 / 258 | 20% | 0.29 | 47 / 230 |
peripheral blood | 74% | 197.78 | 683 / 929 | 0% | 0 | 0 / 0 |
heart | 64% | 21.66 | 555 / 861 | 0% | 0 | 0 / 0 |
liver | 50% | 15.43 | 112 / 226 | 6% | 0.11 | 25 / 406 |
lymph node | 0% | 0 | 0 / 0 | 55% | 1.01 | 16 / 29 |
spleen | 51% | 15.24 | 123 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 49% | 10.27 | 22 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006955 | Biological process | immune response |
GO_0007519 | Biological process | skeletal muscle tissue development |
GO_0060415 | Biological process | muscle tissue morphogenesis |
GO_0006936 | Biological process | muscle contraction |
GO_0033275 | Biological process | actin-myosin filament sliding |
GO_0005829 | Cellular component | cytosol |
GO_0005859 | Cellular component | muscle myosin complex |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0008307 | Molecular function | structural constituent of muscle |
Gene name | MYL11 |
Protein name | Myosin regulatory light chain 11 (Fast skeletal myosin light chain 2) (MLC2B) (Myosin light chain 11) (Myosin regulatory light chain 2, skeletal muscle isoform) Fast skeletal myosin light chain 2 |
Synonyms | HSRLC MYLPF |
Description | FUNCTION: Myosin regulatory subunit that plays an essential role to maintain muscle integrity during early development (By similarity). Plays a role in muscle contraction (By similarity). . |
Accessions | ENST00000563718.5 ENST00000566955.1 H3BN54 ENST00000568749.5 H3BPK4 ENST00000322861.12 H3BML9 Q96A32 |